Abstract
BACKGROUND AND PURPOSE: Zhu-Tokita-Takenouchi-Kim syndrome is a severe multisystem malformation disorder characterized by developmental delay and a diverse array of congenital abnormalities. However, these currently identified phenotypic components provide limited guidance in diagnostic situations, due to both the nonspecificity and variability of these features. Here we report a case series of 7 individuals with a molecular diagnosis of Zhu-Tokita-Takenouchi-Kim syndrome, 5 ascertained by their presentation with the neuronal migration disorder, periventricular nodular heterotopia.
MATERIALS AND METHODS: Individuals with a molecular diagnosis of Zhu-Tokita-Takenouchi-Kim syndrome were recruited from 2 sources, a high-throughput sequencing study of individuals with periventricular nodular heterotopia or from clinical diagnostic sequencing studies. We analyzed available brain MR images of recruited individuals to characterize periventricular nodular heterotopia distribution and to identify the presence of any additional brain abnormalities.
RESULTS: Pathogenic variants in SON, causative of Zhu-Tokita-Takenouchi-Kim syndrome, were identified in 7 individuals. Brain MR images from these individuals were re-analyzed. A characteristic set of imaging anomalies in addition to periventricular nodular heterotopia was identified, including the elongation of the pituitary stalk, cerebellar enlargement with an abnormally shaped posterior fossa, rounding of the caudate nuclei, hippocampal malformations, and cortical anomalies including polymicrogyria or dysgyria.
CONCLUSIONS: The recurrent neuroradiologic changes identified here represent an opportunity to guide diagnostic formulation of Zhu-Tokita-Takenouchi-Kim syndrome on the basis of brain MR imaging evaluation.
ABBREVIATIONS:
- PVNH
- periventricular nodular heterotopia
- VUS
- variant of uncertain significance
- WES
- whole-exome sequencing
- WGS
- whole-genome sequencing
- ZTTK syndrome
- Zhu-Tokita-Takenouchi-Kim syndrome
Footnotes
S.P. Robertson is supported by the Health Research Council and Cure Kids. B.J. Halliday is supported by a University of Otago Doctoral Scholarship. R.J. Leventer is supported by a Melbourne Children’s Clinician Scientist Fellowship. I.E. Scheffer is supported by the Australian National Health and Medical Research Council, the Australian Medical Research Future Fund, and the Australian Epilepsy Research Fund.
Disclosure forms provided by the authors are available with the full text and PDF of this article at www.ajnr.org.
- © 2022 by American Journal of Neuroradiology
Indicates open access to non-subscribers at www.ajnr.org